Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Biotech Analysis Central Pharma News: Cytodyn's Acquisition, Novartis Exits Antibotic Research, Advaxis' FDA Hold Removed [Seeking Alpha]

Advaxis, Inc. (ADXS) 
Last advaxis, inc. earnings: 9/9 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.advaxis.com
Company Research Source: Seeking Alpha
Summary Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. Cytodyn Announced It Will Acquire ProstaGene LLC. News: Recently, Cytodyn ( OTCQB:CYDY ) announced that it would acquire ProstaGene LLC. so that it could extend its pipeline. Cytodyn sent a Letter Of Intent to acquire the company which focuses on creating cancer products that makes use of CCR5 antagonism. With the companies being merged, Richard G. Pestell, M.D., Ph.D. which is the current CEO of ProstaGene will be joining the board of Cytodyn. Cytodyn also made a host of management changes because of this acquisition. Analysis: I believe that this acquisition is a smart one. The reason why I state that is because it expands the pipeline capability of Cytodyn. Currently, Cytodyn has two ongoing programs which are in HIV and Graft-versus-Host-Disease (GVHD). The most advanced program involves the HIV program. Cytodyn Show less Read more
Impact Snapshot
Event Time:
ADXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
ADXS alerts

from News Quantified
Opt-in for
ADXS alerts

from News Quantified